Clinical characteristics of allergic rhinitis induced by pollen in northern China.
10.13201/j.issn.2096-7993.2025.05.014
- Author:
Sinan HE
1
;
Lijia CHEN
1
;
Wenhua MING
1
;
Xiaoyan WANG
1
;
Hongtian WANG
1
;
Xueyan WANG
1
Author Information
1. Department of Allergy，Beijing Shijitan Hospital，Capital Medical University，Beijing，100038，China.
- Publication Type:Journal Article
- Keywords:
allergic comorbidity;
allergic rhinitis;
risk factors;
sensitized pollen;
treatment mode
- MeSH:
Humans;
China/epidemiology*;
Cross-Sectional Studies;
Rhinitis, Allergic, Seasonal/therapy*;
Pollen/immunology*;
Adult;
Male;
Female;
Young Adult;
Adolescent;
Middle Aged;
Child;
Prevalence;
Allergens/immunology*;
Asthma/epidemiology*;
Conjunctivitis, Allergic
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2025;39(5):470-481
- CountryChina
- Language:Chinese
-
Abstract:
Objective:The prevalence of seasonal allergic rhinitis （AR） and its combined diseases have been increasing recently. The purpose was to investigate the clinical characteristics and treatment of seasonal AR in northern China. Methods:A cross-sectional study was conducted in AR patients. The Visual analogue scale （VAS）, combined diseases, clinical features, allergic pollen and treatments were analyzed. Results:Of the 789 AR subjects included, 54.1% had a family history of atopic disease. The mian course wa s（7.4±5.9） years. 95.4% of the subjects had moderate to severe AR. The prevalence rates of allergic conjunctivitis （AC）, allergic asthma （AA）, and pollen food allergy syndrome （PFAS） were 71.1%, 19.0%, and 39.5% respectively. Among the patients, 13.8% presented with only AR, while 39.3% had an AR combined with other disease, and 1.9% exhibited comorbidity involving five different diseases. VAS was positively correlated with the number of comorbidities（r=0.186, P<0.001）. The mugwort exhibited the highest rate of pollen sensitization （48.9%）, closely followed by cypress （48.3%）. The prevalence of mono-sensitization to pollen was 20.2%, while the positive rates for double-sensitized pollens and more than three sensitized pollens were 17.4% and 62.4%, respectively. Among the study participants, 19.9% did not receive any form of treatment, while 66.2% were administered oral medication and 27.5% underwent nasal steroid spray therapy. The proportion of individuals receiving anti-IgE monoclonal antibodies was 4.3%, and allergen immunotherapy （AIT） treatment was undergone by 11.8%. Meanwhile, 41.2% of patients undergoing anti-IgE monoclonal antibody treatment also received AIT. The distribution of therapy types among patients was as follows: 44.7% received a single type, 22.2% received two types, and 9.8% received three types of therapy. Additionally, there was a subset of patients（1%） who were undergoing five distinct forms of treatment. The VAS score exhibited a significant negative correlation with no treatment（r=-0.199, P<0.001）, while it showed a positive association with the number of treatment modalities（r=0.245, P<0.001）. Conclusion:Mugwort and cypress are the predominant allergenic pollens responsible for seasonal AR in northern China. The majority of cases present with moderate to severe AR, often accompanied by various comorbidities, necessitating consideration of diverse treatment modalities. However, the current rate of adoption for AIT remains relatively insufficient.
